CRISPR、RNAi、TALEN一张图教你做出正确选择

2015-05-26 叶予 生物通

研究基因功能最常见的方法是,减少或者阻断基因表达,然后进行表型分析。十多年来,RNAi一直是这一领域的王者,然而新兴技术的涌现(尤其是CRISPR技术)正在逐渐瓦解RNAi的统治地位。日新月异的技术发展为生物学研究提供了越来越大的助力,也给研究者们带来了一个有些纠结的问题,“到底应该选择那一种技术呢”。  1998年Andrew Fire 和Craig Mello两位科学家首次

研究基因功能最常见的方法是,减少或者阻断基因表达,然后进行表型分析。十多年来,RNAi一直是这一领域的王者,然而新兴技术的涌现(尤其是CRISPR技术)正在逐渐瓦解RNAi的统治地位。日新月异的技术发展为生物学研究提供了越来越大的助力,也给研究者们带来了一个有些纠结的问题,“到底应该选择那一种技术呢”。 

1998年Andrew Fire 和Craig Mello两位科学家首次在线虫中证明了RNAi的存在,他们也因此获得了诺贝尔生理/医学奖。2001年马普研究所的科学家们又在哺乳动物中发现了RNAi特异性沉默机制。这一技术随即成为了反向遗传学的重要工具,被视为靶向任何基因的“神奇子弹”。虽然RNAi是一种普遍采用的简单技术,但它属于基因下调(Knockdown)方法,不能完全去除基因的功能。

真正帮助人们实现完全功能缺失的是锌指酶ZFN和TALEN(transcription activator-like effector nucleases)。这些技术使用了可以识别特定DNA序列的DNA结合结构域(DBD),融合了核酸酶的DBD可以向目的基因引入双链断裂(DSB)和突变,最终敲除基因。不过,ZFN和TALEN的光芒很快就被后起之秀CRISPR/Cas所掩盖。 

CRISPR/Cas原本是细菌抵御病毒的重要武器,现在它已经成为了基因组编辑的强大工具。风头正劲的CRISPR/Cas不仅操作简便,而且还有着很强的可扩展性,被广泛应用到各种生物中,催生了大量的研究成果。根据功能元件的不同,CRISPR/Cas系统可以分为I类系统、II类系统和III类系统。目前使用最为广泛的是酿脓链球菌的II型CRISPR/Cas9,它已经被成功用于编辑人类基因组。

最新一期Molecular Cell杂志推出了技术特刊,介绍了生物学领域近年来出现的新兴技术。其中一篇文章对RNAi、TALEN和CRISPR这三大工具的核心技术进行了全面比较,并且为基因功能研究提供了一份实用指南。(现在这篇文章可以免费下载)研究者们可以根据自己的需要,简单直观的找到最适合自己的技术。 

RNAi、TALEN和CRISPR选择指南(见下图)


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1751653, encodeId=446f1e5165322, content=<a href='/topic/show?id=2c2c1553e56' target=_blank style='color:#2F92EE;'>#RNAi#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15537, encryptionId=2c2c1553e56, topicName=RNAi)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9d436366397, createdName=yinxm8315, createdTime=Thu Feb 04 04:21:00 CST 2016, time=2016-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25635, encodeId=76ce2563504, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 31 21:36:00 CST 2015, time=2015-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275833, encodeId=d98112e5833fc, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5211, encryptionId=755d5211a0, topicName=CRISPR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Thu May 28 07:21:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24973, encodeId=e823249e392, content=真正的学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150526/IMG5564536F3C41D5237.jpg, createdBy=4c0c1612254, createdName=summer474cn, createdTime=Tue May 26 19:41:00 CST 2015, time=2015-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24958, encodeId=4ab72495846, content=赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/D26s4tMwZbRicDx7kCqw3ZhsUu5Xqw61EKDTCNyMwj0DnclBCmVmD1q3xJ8dkLEibbgBgkGicFEEB6kviags8Dar4A/132, createdBy=857c100601, createdName=lisalin, createdTime=Tue May 26 16:52:00 CST 2015, time=2015-05-26, status=1, ipAttribution=)]
    2016-02-04 yinxm8315
  2. [GetPortalCommentsPageByObjectIdResponse(id=1751653, encodeId=446f1e5165322, content=<a href='/topic/show?id=2c2c1553e56' target=_blank style='color:#2F92EE;'>#RNAi#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15537, encryptionId=2c2c1553e56, topicName=RNAi)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9d436366397, createdName=yinxm8315, createdTime=Thu Feb 04 04:21:00 CST 2016, time=2016-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25635, encodeId=76ce2563504, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 31 21:36:00 CST 2015, time=2015-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275833, encodeId=d98112e5833fc, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5211, encryptionId=755d5211a0, topicName=CRISPR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Thu May 28 07:21:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24973, encodeId=e823249e392, content=真正的学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150526/IMG5564536F3C41D5237.jpg, createdBy=4c0c1612254, createdName=summer474cn, createdTime=Tue May 26 19:41:00 CST 2015, time=2015-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24958, encodeId=4ab72495846, content=赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/D26s4tMwZbRicDx7kCqw3ZhsUu5Xqw61EKDTCNyMwj0DnclBCmVmD1q3xJ8dkLEibbgBgkGicFEEB6kviags8Dar4A/132, createdBy=857c100601, createdName=lisalin, createdTime=Tue May 26 16:52:00 CST 2015, time=2015-05-26, status=1, ipAttribution=)]
    2015-05-31 huaxipanxing

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1751653, encodeId=446f1e5165322, content=<a href='/topic/show?id=2c2c1553e56' target=_blank style='color:#2F92EE;'>#RNAi#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15537, encryptionId=2c2c1553e56, topicName=RNAi)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9d436366397, createdName=yinxm8315, createdTime=Thu Feb 04 04:21:00 CST 2016, time=2016-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25635, encodeId=76ce2563504, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 31 21:36:00 CST 2015, time=2015-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275833, encodeId=d98112e5833fc, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5211, encryptionId=755d5211a0, topicName=CRISPR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Thu May 28 07:21:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24973, encodeId=e823249e392, content=真正的学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150526/IMG5564536F3C41D5237.jpg, createdBy=4c0c1612254, createdName=summer474cn, createdTime=Tue May 26 19:41:00 CST 2015, time=2015-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24958, encodeId=4ab72495846, content=赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/D26s4tMwZbRicDx7kCqw3ZhsUu5Xqw61EKDTCNyMwj0DnclBCmVmD1q3xJ8dkLEibbgBgkGicFEEB6kviags8Dar4A/132, createdBy=857c100601, createdName=lisalin, createdTime=Tue May 26 16:52:00 CST 2015, time=2015-05-26, status=1, ipAttribution=)]
    2015-05-28 yuandd
  4. [GetPortalCommentsPageByObjectIdResponse(id=1751653, encodeId=446f1e5165322, content=<a href='/topic/show?id=2c2c1553e56' target=_blank style='color:#2F92EE;'>#RNAi#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15537, encryptionId=2c2c1553e56, topicName=RNAi)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9d436366397, createdName=yinxm8315, createdTime=Thu Feb 04 04:21:00 CST 2016, time=2016-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25635, encodeId=76ce2563504, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 31 21:36:00 CST 2015, time=2015-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275833, encodeId=d98112e5833fc, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5211, encryptionId=755d5211a0, topicName=CRISPR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Thu May 28 07:21:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24973, encodeId=e823249e392, content=真正的学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150526/IMG5564536F3C41D5237.jpg, createdBy=4c0c1612254, createdName=summer474cn, createdTime=Tue May 26 19:41:00 CST 2015, time=2015-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24958, encodeId=4ab72495846, content=赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/D26s4tMwZbRicDx7kCqw3ZhsUu5Xqw61EKDTCNyMwj0DnclBCmVmD1q3xJ8dkLEibbgBgkGicFEEB6kviags8Dar4A/132, createdBy=857c100601, createdName=lisalin, createdTime=Tue May 26 16:52:00 CST 2015, time=2015-05-26, status=1, ipAttribution=)]
    2015-05-26 summer474cn

    真正的学习了!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1751653, encodeId=446f1e5165322, content=<a href='/topic/show?id=2c2c1553e56' target=_blank style='color:#2F92EE;'>#RNAi#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15537, encryptionId=2c2c1553e56, topicName=RNAi)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9d436366397, createdName=yinxm8315, createdTime=Thu Feb 04 04:21:00 CST 2016, time=2016-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25635, encodeId=76ce2563504, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 31 21:36:00 CST 2015, time=2015-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275833, encodeId=d98112e5833fc, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5211, encryptionId=755d5211a0, topicName=CRISPR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Thu May 28 07:21:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24973, encodeId=e823249e392, content=真正的学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150526/IMG5564536F3C41D5237.jpg, createdBy=4c0c1612254, createdName=summer474cn, createdTime=Tue May 26 19:41:00 CST 2015, time=2015-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24958, encodeId=4ab72495846, content=赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/D26s4tMwZbRicDx7kCqw3ZhsUu5Xqw61EKDTCNyMwj0DnclBCmVmD1q3xJ8dkLEibbgBgkGicFEEB6kviags8Dar4A/132, createdBy=857c100601, createdName=lisalin, createdTime=Tue May 26 16:52:00 CST 2015, time=2015-05-26, status=1, ipAttribution=)]
    2015-05-26 lisalin

    赞!

    0

相关资讯

Science:越来越野蛮的基因编辑技术

2014年12月28日,来自美国UCSD的Valentino Gantz以及Ethan Bier教授查对了他们实验室里刚刚孵化的果蝇。该实验的果蝇母本其中一条X染色体上的控制体色的基因发生了突变。按常规的孟德尔遗传定律,子代出现带有体色变化的隐性纯合子果蝇的概率为1/4,而他们的实验中后代果蝇几乎都是突变的表型!(浅黄色体色)。作为Valentino Gantz的导师,Bier教授感觉就像是太阳从

CRISPR技术剪掉HIV病毒基因,根治艾滋病

艾滋病病毒是一种高效且多变的逆转录病毒。一旦病毒将其DNA插入宿主细胞的基因组,它即拥有很长的潜伏期,可以保持休眠和隐匿状态达数年之久。 虽然医生可以通过多种不同的抗逆转录病毒药物搭配使用的鸡尾酒疗法来控制病毒,但若停止治疗,病毒即可恢复活力。 为了使潜伏中的艾滋病病毒失活,马萨诸塞大学医学院(University of Massachusetts Medical School

Nature:再掀学术伦理之争!中国科学家瞄准人类胚胎基因改造

中国科学家走在世界的第一位,首次报道成果对人类胚胎的基因进行改造。该项研究结果在线发表在最新一期 Protein & Cell 杂志上。这一消息正式确认了科学界关于对人类胚胎基因研究工作正在开展的谣言,而后者因伦理问题在上个月引起了激烈的讨论。 在这项由中山大学基因功能学教授Jun-jiu Huang所主持的研究中,研究人员利用来自当地生殖医疗机构“不能存活”的胚

Nat Commun:CRISPR系统初步成功清除HIV病毒

想象一下,一个成分单一的药物,可以防止人类免疫缺陷病毒(HIV)感染,也能治疗已经感染艾滋病毒的患者,甚至能清除比HIV更厉害的病毒的所有休眠副本。这听起来像科幻小说,但已经有科学家们开始一步步接近于这个目标。他们通过定义和利用细菌和基因剪刀手CRISPR/Cas9系统,为细胞创造了一个新的防御系统。这篇研究成果,发表在最新的Nature Communications。 当HIV病毒复制潜

PNAS:用CRISPR解决世界性难题

近年来致病菌的抗生素抗性越演越烈,这已经成为了一个世界性的难题。科学家们日前在CRISPR技术的基础上,开发了一个双噬菌体系统,能够使耐药菌敏感化,并且有选择的杀死它们。这项研究发表在五月十八日的美国国家科学院院刊PNAS杂志上。传统的噬菌体疗法是用一种或多种噬菌体去感染和裂解相应的细菌菌株。不过,把噬菌体递送到被感染的组织还存在一定的困难。Tel Aviv大学Udi Qimron等人开发的这种改

Nat Biotech:科学家成功能将CRISPR/Cas9效率提高19倍

  CRISPR/Cas系统可以构建出多个基因精确突变的小鼠,但其效率低下阻碍了生成足够数量的转基因小鼠来建立人类疾病模型。通过添加一种抗癌药物Scr7到遗传编辑的受精卵中,Whitehead研究所的科学家将CRISPR/Cas的效率显着提高了19倍。这一重要的成果发表在本周的《自然生物技术》(Nature Biotechnology)杂志上。 CRISPR- Cas系统是通过在